Hyperaccelerated Award/Mechanisms in Immunomodulation Trials - Addendum to RFA-AI-04-001
Funding Contact(s): Ursula Utz, Ph.D.
Funding Categories: Neural Environment
Brief Description:
The participating Institutes intend to commit approximately $1,100,000 in FY 2005 to fund 3 to 4 new grants for immune mechanistic,
ancillary studies of immunomodulatory interventions for immune system mediated diseases clinical trials and of vaccine clinical
trials for non-HIV/AIDS infectious diseases. NIAID does not have specified funds committed in FY 2005 as were available in
FY 2004 for immune mechanistic ancillary studies of vaccine clinical trials for the prevention and treatment NIAID Category
A, B and C agents of bioterrorism and non-HIV/AIDS emerging/re-emerging infectious diseases, however, these applications
are responsive to this RFA.